De Ieso Michael L, Yool Andrea J
Department of Physiology, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
Front Chem. 2018 Apr 25;6:135. doi: 10.3389/fchem.2018.00135. eCollection 2018.
Cancer is a leading cause of death worldwide, and its incidence is rising with numbers expected to increase 70% in the next two decades. The fact that current mainline treatments for cancer patients are accompanied by debilitating side effects prompts a growing demand for new therapies that not only inhibit growth and proliferation of cancer cells, but also control invasion and metastasis. One class of targets gaining international attention is the aquaporins, a family of membrane-spanning water channels with diverse physiological functions and extensive tissue-specific distributions in humans. Aquaporins-1,-2,-3,-4,-5,-8, and-9 have been linked to roles in cancer invasion, and metastasis, but their mechanisms of action remain to be fully defined. Aquaporins are implicated in the metastatic cascade in processes of angiogenesis, cellular dissociation, migration, and invasion. Cancer invasion and metastasis are proposed to be potentiated by aquaporins in boosting tumor angiogenesis, enhancing cell volume regulation, regulating cell-cell and cell-matrix adhesions, interacting with actin cytoskeleton, regulating proteases and extracellular-matrix degrading molecules, contributing to the regulation of epithelial-mesenchymal transitions, and interacting with signaling pathways enabling motility and invasion. Pharmacological modulators of aquaporin channels are being identified and tested for therapeutic potential, including compounds derived from loop diuretics, metal-containing organic compounds, plant natural products, and other small molecules. Further studies on aquaporin-dependent functions in cancer metastasis are needed to define the differential contributions of different classes of aquaporin channels to regulation of fluid balance, cell volume, small solute transport, signal transduction, their possible relevance as rate limiting steps, and potential values as therapeutic targets for invasion and metastasis.
癌症是全球主要的死亡原因之一,其发病率正在上升,预计在未来二十年将增加70%。目前癌症患者的主流治疗方法伴随着使人衰弱的副作用,这一事实促使人们对新疗法的需求不断增加,这些新疗法不仅能抑制癌细胞的生长和增殖,还能控制侵袭和转移。一类受到国际关注的靶点是水通道蛋白,这是一族跨膜水通道,在人类中具有多种生理功能和广泛的组织特异性分布。水通道蛋白-1、-2、-3、-4、-5、-8和-9与癌症侵袭和转移有关,但其作用机制仍有待充分明确。水通道蛋白在血管生成、细胞解离、迁移和侵袭过程的转移级联反应中发挥作用。癌症侵袭和转移被认为是由水通道蛋白增强肿瘤血管生成、增强细胞体积调节、调节细胞间和细胞与基质的粘附、与肌动蛋白细胞骨架相互作用、调节蛋白酶和细胞外基质降解分子、促进上皮-间质转化的调节以及与使细胞运动和侵袭的信号通路相互作用而增强的。水通道蛋白通道的药理学调节剂正在被鉴定和测试其治疗潜力,包括来自襻利尿剂的化合物、含金属的有机化合物、植物天然产物和其他小分子。需要进一步研究水通道蛋白在癌症转移中的依赖性功能来确定不同类别的水通道蛋白通道对液体平衡调节、细胞体积、小溶质转运、信号转导的不同贡献,它们作为限速步骤的可能相关性以及作为侵袭和转移治疗靶点的潜在价值。